These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 12515033)

  • 1. Abstracts of DC2007 the 5th International Meeting on Dendritic Cell Vaccination and other Strategies to Tip the Balance of the Immune System. July 16-18, 2007. Bamberg, Germany.
    Cancer Immunol Immunother; 2008 Feb; 57 Suppl 1(Suppl 1):S1-53. PubMed ID: 18236043
    [No Abstract]   [Full Text] [Related]  

  • 2. Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA).
    Salgaller ML; Lodge PA; McLean JG; Tjoa BA; Loftus DJ; Ragde H; Kenny GM; Rogers M; Boynton AL; Murphy GP
    Prostate; 1998 May; 35(2):144-51. PubMed ID: 9568678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trial.
    Lodge PA; Jones LA; Bader RA; Murphy GP; Salgaller ML
    Cancer Res; 2000 Feb; 60(4):829-33. PubMed ID: 10706088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of prostate tumor cells by cytotoxic T lymphocytes specific for prostate-specific membrane antigen.
    Lu J; Celis E
    Cancer Res; 2002 Oct; 62(20):5807-12. PubMed ID: 12384542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells.
    Small EJ; Fratesi P; Reese DM; Strang G; Laus R; Peshwa MV; Valone FH
    J Clin Oncol; 2000 Dec; 18(23):3894-903. PubMed ID: 11099318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Active specific immune therapy of prostate gland cancer].
    Chakŭrov S; Minchev M
    Khirurgiia (Sofiia); 2002; 58(1):32-8. PubMed ID: 12515033
    [No Abstract]   [Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor-transduced allogeneic cancer cellular immunotherapy: the GVAX vaccine for prostate cancer.
    Simons JW; Sacks N
    Urol Oncol; 2006; 24(5):419-24. PubMed ID: 16962494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cell therapy and prostate cancer].
    Eymard JC; Bernard J
    Bull Cancer; 2003; 90(8-9):734-43. PubMed ID: 14609763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on prostate cancer vaccines.
    Drake CG
    Cancer J; 2011; 17(5):294-9. PubMed ID: 21952278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccines: an active immunization strategy for prostate cancer.
    Wolchok JD; Gregor PD; Nordquist LT; Slovin SF; Scher HI
    Semin Oncol; 2003 Oct; 30(5):659-66. PubMed ID: 14571413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor vaccines for the management of prostate cancer.
    McNeel DG; Disis ML
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):85-93. PubMed ID: 10807048
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.